232 related articles for article (PubMed ID: 24055710)
21. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
23. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.
Siegrist CA; Martinez-Soria E; Kern I; Mach B
J Exp Med; 1995 Dec; 182(6):1793-9. PubMed ID: 7500024
[TBL] [Abstract][Full Text] [Related]
24. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
Murphy SP; Tomasi TB
Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
[TBL] [Abstract][Full Text] [Related]
26. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
[TBL] [Abstract][Full Text] [Related]
27. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
Taxman DJ; Cressman DE; Ting JP
J Immunol; 2000 Aug; 165(3):1410-6. PubMed ID: 10903745
[TBL] [Abstract][Full Text] [Related]
28. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain.
Yun S; Gustafsson K; Fabre JW
Transplantation; 1998 Jul; 66(1):103-11. PubMed ID: 9679829
[TBL] [Abstract][Full Text] [Related]
29. Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA.
Quan V; Towey M; Sacks S; Kelly AP
Immunogenetics; 1999 Oct; 49(11-12):957-63. PubMed ID: 10501838
[TBL] [Abstract][Full Text] [Related]
30. [Study of HLA molecules and its associated genes expression in human ovarian cancer cells].
Ge HL; Zhang XR; Wang Y; Ma AL; Zhang HZ; Wang SJ; Zhou GY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):41-4. PubMed ID: 15132903
[TBL] [Abstract][Full Text] [Related]
31. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
[TBL] [Abstract][Full Text] [Related]
32. X box-like sequences in the MHC class II region maintain regulatory function.
Gomez JA; Majumder P; Nagarajan UM; Boss JM
J Immunol; 2005 Jul; 175(2):1030-40. PubMed ID: 16002703
[TBL] [Abstract][Full Text] [Related]
33. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
34. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
Steimle V; Otten LA; Zufferey M; Mach B
Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
[TBL] [Abstract][Full Text] [Related]
35. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.
Kern I; Steimle V; Siegrist CA; Mach B
Int Immunol; 1995 Aug; 7(8):1295-9. PubMed ID: 7495736
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the transcriptional regulation of classical and non-classical MHC class II genes.
Hake SB; Tobin HM; Steimle V; Denzin LK
Eur J Immunol; 2003 Sep; 33(9):2361-71. PubMed ID: 12938212
[TBL] [Abstract][Full Text] [Related]
37. Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
Chang CH; Flavell RA
J Exp Med; 1995 Feb; 181(2):765-7. PubMed ID: 7836928
[TBL] [Abstract][Full Text] [Related]
38. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
Kanazawa S; Peterlin BM
Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
[TBL] [Abstract][Full Text] [Related]
39. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
[TBL] [Abstract][Full Text] [Related]
40. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium.
Muczynski KA; Cotner T; Anderson SK
Kidney Int; 2001 Feb; 59(2):488-97. PubMed ID: 11168931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
